Coherent Work in process increased by 12.8% to $1.24B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 66.0%, from $745.89M to $1.24B. Over 4 years (FY 2021 to FY 2025), Work in process shows an upward trend with a 25.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $336.39M | $357.87M | $370.66M | $386.04M | $408.41M | $581.75M | $608.78M | $621.30M | $549.99M | $576.20M | $604.63M | $628.45M | $620.58M | $736.43M | $730.09M | $745.89M | $824.36M | $952.95M | $1.10B | $1.24B |
| QoQ Change | — | +6.4% | +3.6% | +4.2% | +5.8% | +42.4% | +4.6% | +2.1% | -11.5% | +4.8% | +4.9% | +3.9% | -1.3% | +18.7% | -0.9% | +2.2% | +10.5% | +15.6% | +15.2% | +12.8% |
| YoY Change | — | — | — | — | +21.4% | +62.6% | +64.2% | +60.9% | +34.7% | -1.0% | -0.7% | +1.2% | +12.8% | +27.8% | +20.7% | +18.7% | +32.8% | +29.4% | +50.3% | +66.0% |
| % of Inventories | 48.3% | 47.9% | 45.3% | 43.9% | 45.2% | 43.2% | 44.5% | 44.6% | 43.2% | 45.0% | 46.8% | 48.7% | 48.2% | 53.1% | 54.3% | 53.6% | 57.3% | 58.4% | 59.4% | 58.2% |
| Share Change | — | -0.5pp | -2.6pp | -1.4pp | +1.4pp | -2.1pp | +1.3pp | +0.0pp | -1.3pp | +1.8pp | +1.8pp | +1.8pp | -0.4pp | +4.9pp | +1.2pp | -0.7pp | +3.7pp | +1.0pp | +1.0pp | -1.2pp |